Med Page Today
SEPTEMBER 28, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
HCPLive
SEPTEMBER 28, 2024
Alcohol intake frequency was linked to a greater risk of IgAN, while dietary exposures like cheese, cereal, and sushi were associated with a reduced risk.
Ken Grauer, MD
SEPTEMBER 28, 2024
The ECG in Figure-1 — was obtained from a 45-year old man with diabetes, who was being treated for septic shock. QUESTIONS: How would YOU interpret the ECG in Figure-1 ? What is the rhythm? Why does QRS morphology in the long lead II rhythm strip change every-other-beat? Figure-1: The initial ECG in today's case. MY Thoughts on the ECG in Figure-1: This is a challenging ECG to interpret because of: i ) the changing QRS morphology; and , ii ) the difficulty in seeing all of the P waves.
Dr. Paddy Barrett
SEPTEMBER 28, 2024
It's Christmas 2014, and I am flying to New York City. I am returning after a brief visit home to Ireland to continue my training as an interventional cardiologist in the US. But something is terribly wrong. Central Park. Winter 2014. Subway closed. Walking to work. I am training at one of the most prestigious centres in the US and possibly the world.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Circulation
SEPTEMBER 28, 2024
Circulation, Volume 151, Issue 2 , Page 149-158, January 14, 2025. BACKGROUND:Patients with heart failure (HF) with mildly reduced or preserved ejection fraction face heightened long-term risks of morbidity and mortality. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and the nonsteroidal mineralocorticoid receptor antagonist finerenone have both been shown to reduce the risk of cardiovascular events in this population, but the effects of their combined use are not known.METHODS:FINEARTS-HF
HCPLive
SEPTEMBER 28, 2024
HCPLive spoke to Rodriguez, MD, MPH, about implementing AI in cardiology care.
HCPLive
SEPTEMBER 28, 2024
In this interview at EADV, Thaçi was asked to highlight his team’s recent data from the ARCADIA trial program on nemolizumab for patients with eczema.
Expert insights. Personalized for you.
110 
Let's personalize your content